The nation of Zimbabwe has turned down a major US health deal valued at $367m (£272m) spanning five years because of Washington's demand for confidential biological samples.
This rejection was revealed after a government memo from December was disclosed, revealing that President Emmerson Mnangagwa deemed the agreement was "lopsided".
A government spokesperson has since clarified that the US was seeking genetic material for scientific study and commercial gain but was not willing to guarantee the resulting advantages from future vaccines.
"We are forced to start the difficult and regrettable task of ending our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had provided more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for further talks to secure a deal acceptable to all parties so the nation's critical HIV programme can be sustained.
Wider Implications
This development follows a comparable situation in Kenya, where a court suspended a related deal with the US following legal challenges were raised about the safety of Kenyans' medical information.
Since resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump claimed its spending was "wasteful" and his administration was pursuing government-to-government agreements to boost openness and responsibility.
Based on reports, Sixteen nations in Africa have so far signed these new health pacts, constituting over $18.3bn in new funding.
Details of the Rejected Agreement
The funds for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration could have provided extraordinary advantages for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment via US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, without any equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"Put simply, our country would supply the basic resources for scientific discovery without any certainty that the final treatments would be available to our population should a new disease outbreak arise."
National Interest and International Frameworks
He also said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining frameworks already established via the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future pandemics.
"This framework is designed to ensure that when a country provides its information, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
These objections over the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome further dialogue with our US partners on how subsequent collaboration could be arranged in a manner that honours the sovereignty and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but recommended that talks must proceed given that a large portion of the country's Aids initiatives depended on external financing.
"If specific concerns arise, including those relating to information security or agreement terms, these can often be resolved through detailed discussion and negotiated safeguards," it added.
The halted deal underscores the continuing challenges between receiving crucial international aid and safeguarding local interests in an ever more interconnected world.